+467.0%
MRNA vs CLX
-25.9%
+492.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CLX | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -1.1% | +6.5% | +6.0% |
| 7D | -1.1% | -5.7% | +4.6% | +2.3% |
| 30D | +126.1% | -17.0% | +143.1% | +153.4% |
| 3M | +190.0% | -9.7% | +199.7% | +221.3% |
| 6M | +157.2% | -19.8% | +177.1% | +193.2% |
| YTD | +388.2% | -9.8% | +398.0% | +423.5% |
| 1Y | +467.0% | -26.2% | +493.2% | +563.4% |
| All | +467.0% | -25.9% | +492.9% | +563.4% |
Cumulative growth
Daily Returns
Daily percentage return beside CLX.
Daily Out/Under-Performance
Portfolio return minus CLX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CLX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CLX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling